BioStem grows hospital revenue again, raises 2026 revenue outlookNov 12Quarterly updateBioStem Technologies
BioStem completes BR-AC venous ulcer trial; Kardigan finishes KATALYST-AV aortic stenosis enrollmentNov 4Trial updateBioStem TechnologiesKardigan
BioStem files Form D for $3 million offering tied to September private placementOct 9FinancingBioStem TechnologiesUpdated
BioStem Technologies registers $40 million stock facility, files related Form DSep 21FinancingBioStem Technologies
BioStem Technologies enters $40 million committed equity facility with RothSep 18FinancingBioStem Technologies
BioStem Technologies posts Q2 2026 revenue growth, completes Nasdaq uplistingAug 12Quarterly updateBioStem Technologies
BioStem Technologies files S-1 for resale of up to 3.57 million sharesJul 29FinancingBioStem Technologies